Global Drugs for Treating Mental Disorders Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Drugs for Treating Mental Disorders Industry Forecast” looks at past sales and reviews total world Drugs for Treating Mental Disorders sales in 2022, providing a comprehensive analysis by region and market sector of projected Drugs for Treating Mental Disorders sales for 2023 through 2029. With Drugs for Treating Mental Disorders sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drugs for Treating Mental Disorders industry.
This Insight Report provides a comprehensive analysis of the global Drugs for Treating Mental Disorders landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drugs for Treating Mental Disorders portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Drugs for Treating Mental Disorders market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drugs for Treating Mental Disorders and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drugs for Treating Mental Disorders.
The global Drugs for Treating Mental Disorders market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Drugs for Treating Mental Disorders is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Drugs for Treating Mental Disorders is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Drugs for Treating Mental Disorders is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Drugs for Treating Mental Disorders players cover Johnson and Johnson, Pfizer, Eli Lilly, GlaxoSmithKline, AstraZeneca, Bristol-Myers Squibb, Teva Pharmaceutical, Dr. Reddy's Laboratories and Apotex Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Drugs for Treating Mental Disorders market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
LPI (LP Information)' newest research report, the “Drugs for Treating Mental Disorders Industry Forecast” looks at past sales and reviews total world Drugs for Treating Mental Disorders sales in 2022, providing a comprehensive analysis by region and market sector of projected Drugs for Treating Mental Disorders sales for 2023 through 2029. With Drugs for Treating Mental Disorders sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drugs for Treating Mental Disorders industry.
This Insight Report provides a comprehensive analysis of the global Drugs for Treating Mental Disorders landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drugs for Treating Mental Disorders portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Drugs for Treating Mental Disorders market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drugs for Treating Mental Disorders and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drugs for Treating Mental Disorders.
The global Drugs for Treating Mental Disorders market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Drugs for Treating Mental Disorders is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Drugs for Treating Mental Disorders is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Drugs for Treating Mental Disorders is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Drugs for Treating Mental Disorders players cover Johnson and Johnson, Pfizer, Eli Lilly, GlaxoSmithKline, AstraZeneca, Bristol-Myers Squibb, Teva Pharmaceutical, Dr. Reddy's Laboratories and Apotex Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Drugs for Treating Mental Disorders market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Tablets
- Capsule
- Injection
- Solution
- Other
- Antipsychotics
- Antidepressants
- Antianxiety (Anxiolyitcs)
- Anti-Seizure Medications
- Stimulants
- Cognitive Disorders And Dementia
- Sleep Disorder Treatments
- Substance Abuse Treatments
- Hypnosis And Tranquilizers
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Johnson and Johnson
- Pfizer
- Eli Lilly
- GlaxoSmithKline
- AstraZeneca
- Bristol-Myers Squibb
- Teva Pharmaceutical
- Dr. Reddy's Laboratories
- Apotex Inc.
- Mylan Pharmaceuticals
- Par Pharmaceutical
- Aurobindo Pharma
- Torrent Pharmaceuticals
- Jubilant Lifesciences
- Sun Pharmaceutical
- Sandoz (Novartis)
- Hansoh Pharmaceutical
- WATSON Pharmaceuticals
- Zhejiang Langhua Pharmaceuticals
- Forest Laboratories
- H.Lundbeck A/S
- Amneal Pharmaceuticals
- Hetero Drugs
- Macleods Pharmaceuticals
- Silarx Pharmacueticals
- Hikma Pharmaceuticals
- Lupin Limited
- Prinston Pharmaceutical
- STI Pharma
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drugs for Treating Mental Disorders Market Size 2018-2029
2.1.2 Drugs for Treating Mental Disorders Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Drugs for Treating Mental Disorders Segment by Type
2.2.1 Tablets
2.2.2 Capsule
2.2.3 Injection
2.2.4 Solution
2.2.5 Other
2.3 Drugs for Treating Mental Disorders Market Size by Type
2.3.1 Drugs for Treating Mental Disorders Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Drugs for Treating Mental Disorders Market Size Market Share by Type (2018-2023)
2.4 Drugs for Treating Mental Disorders Segment by Application
2.4.1 Antipsychotics
2.4.2 Antidepressants
2.4.3 Antianxiety (Anxiolyitcs)
2.4.4 Anti-Seizure Medications
2.4.5 Stimulants
2.4.6 Cognitive Disorders And Dementia
2.4.7 Sleep Disorder Treatments
2.4.8 Substance Abuse Treatments
2.4.9 Hypnosis And Tranquilizers
2.4.10 Other
2.5 Drugs for Treating Mental Disorders Market Size by Application
2.5.1 Drugs for Treating Mental Disorders Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Drugs for Treating Mental Disorders Market Size Market Share by Application (2018-2023)
3 DRUGS FOR TREATING MENTAL DISORDERS MARKET SIZE BY PLAYER
3.1 Drugs for Treating Mental Disorders Market Size Market Share by Players
3.1.1 Global Drugs for Treating Mental Disorders Revenue by Players (2018-2023)
3.1.2 Global Drugs for Treating Mental Disorders Revenue Market Share by Players (2018-2023)
3.2 Global Drugs for Treating Mental Disorders Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 DRUGS FOR TREATING MENTAL DISORDERS BY REGIONS
4.1 Drugs for Treating Mental Disorders Market Size by Regions (2018-2023)
4.2 Americas Drugs for Treating Mental Disorders Market Size Growth (2018-2023)
4.3 APAC Drugs for Treating Mental Disorders Market Size Growth (2018-2023)
4.4 Europe Drugs for Treating Mental Disorders Market Size Growth (2018-2023)
4.5 Middle East & Africa Drugs for Treating Mental Disorders Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Drugs for Treating Mental Disorders Market Size by Country (2018-2023)
5.2 Americas Drugs for Treating Mental Disorders Market Size by Type (2018-2023)
5.3 Americas Drugs for Treating Mental Disorders Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drugs for Treating Mental Disorders Market Size by Region (2018-2023)
6.2 APAC Drugs for Treating Mental Disorders Market Size by Type (2018-2023)
6.3 APAC Drugs for Treating Mental Disorders Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Drugs for Treating Mental Disorders by Country (2018-2023)
7.2 Europe Drugs for Treating Mental Disorders Market Size by Type (2018-2023)
7.3 Europe Drugs for Treating Mental Disorders Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drugs for Treating Mental Disorders by Region (2018-2023)
8.2 Middle East & Africa Drugs for Treating Mental Disorders Market Size by Type (2018-2023)
8.3 Middle East & Africa Drugs for Treating Mental Disorders Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL DRUGS FOR TREATING MENTAL DISORDERS MARKET FORECAST
10.1 Global Drugs for Treating Mental Disorders Forecast by Regions (2024-2029)
10.1.1 Global Drugs for Treating Mental Disorders Forecast by Regions (2024-2029)
10.1.2 Americas Drugs for Treating Mental Disorders Forecast
10.1.3 APAC Drugs for Treating Mental Disorders Forecast
10.1.4 Europe Drugs for Treating Mental Disorders Forecast
10.1.5 Middle East & Africa Drugs for Treating Mental Disorders Forecast
10.2 Americas Drugs for Treating Mental Disorders Forecast by Country (2024-2029)
10.2.1 United States Drugs for Treating Mental Disorders Market Forecast
10.2.2 Canada Drugs for Treating Mental Disorders Market Forecast
10.2.3 Mexico Drugs for Treating Mental Disorders Market Forecast
10.2.4 Brazil Drugs for Treating Mental Disorders Market Forecast
10.3 APAC Drugs for Treating Mental Disorders Forecast by Region (2024-2029)
10.3.1 China Drugs for Treating Mental Disorders Market Forecast
10.3.2 Japan Drugs for Treating Mental Disorders Market Forecast
10.3.3 Korea Drugs for Treating Mental Disorders Market Forecast
10.3.4 Southeast Asia Drugs for Treating Mental Disorders Market Forecast
10.3.5 India Drugs for Treating Mental Disorders Market Forecast
10.3.6 Australia Drugs for Treating Mental Disorders Market Forecast
10.4 Europe Drugs for Treating Mental Disorders Forecast by Country (2024-2029)
10.4.1 Germany Drugs for Treating Mental Disorders Market Forecast
10.4.2 France Drugs for Treating Mental Disorders Market Forecast
10.4.3 UK Drugs for Treating Mental Disorders Market Forecast
10.4.4 Italy Drugs for Treating Mental Disorders Market Forecast
10.4.5 Russia Drugs for Treating Mental Disorders Market Forecast
10.5 Middle East & Africa Drugs for Treating Mental Disorders Forecast by Region (2024-2029)
10.5.1 Egypt Drugs for Treating Mental Disorders Market Forecast
10.5.2 South Africa Drugs for Treating Mental Disorders Market Forecast
10.5.3 Israel Drugs for Treating Mental Disorders Market Forecast
10.5.4 Turkey Drugs for Treating Mental Disorders Market Forecast
10.5.5 GCC Countries Drugs for Treating Mental Disorders Market Forecast
10.6 Global Drugs for Treating Mental Disorders Forecast by Type (2024-2029)
10.7 Global Drugs for Treating Mental Disorders Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Johnson and Johnson
11.1.1 Johnson and Johnson Company Information
11.1.2 Johnson and Johnson Drugs for Treating Mental Disorders Product Offered
11.1.3 Johnson and Johnson Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Johnson and Johnson Main Business Overview
11.1.5 Johnson and Johnson Latest Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Drugs for Treating Mental Disorders Product Offered
11.2.3 Pfizer Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Pfizer Main Business Overview
11.2.5 Pfizer Latest Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Company Information
11.3.2 Eli Lilly Drugs for Treating Mental Disorders Product Offered
11.3.3 Eli Lilly Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Eli Lilly Main Business Overview
11.3.5 Eli Lilly Latest Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Information
11.4.2 GlaxoSmithKline Drugs for Treating Mental Disorders Product Offered
11.4.3 GlaxoSmithKline Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 GlaxoSmithKline Main Business Overview
11.4.5 GlaxoSmithKline Latest Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Company Information
11.5.2 AstraZeneca Drugs for Treating Mental Disorders Product Offered
11.5.3 AstraZeneca Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 AstraZeneca Main Business Overview
11.5.5 AstraZeneca Latest Developments
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Information
11.6.2 Bristol-Myers Squibb Drugs for Treating Mental Disorders Product Offered
11.6.3 Bristol-Myers Squibb Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Bristol-Myers Squibb Main Business Overview
11.6.5 Bristol-Myers Squibb Latest Developments
11.7 Teva Pharmaceutical
11.7.1 Teva Pharmaceutical Company Information
11.7.2 Teva Pharmaceutical Drugs for Treating Mental Disorders Product Offered
11.7.3 Teva Pharmaceutical Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Teva Pharmaceutical Main Business Overview
11.7.5 Teva Pharmaceutical Latest Developments
11.8 Dr. Reddy's Laboratories
11.8.1 Dr. Reddy's Laboratories Company Information
11.8.2 Dr. Reddy's Laboratories Drugs for Treating Mental Disorders Product Offered
11.8.3 Dr. Reddy's Laboratories Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Dr. Reddy's Laboratories Main Business Overview
11.8.5 Dr. Reddy's Laboratories Latest Developments
11.9 Apotex Inc.
11.9.1 Apotex Inc. Company Information
11.9.2 Apotex Inc. Drugs for Treating Mental Disorders Product Offered
11.9.3 Apotex Inc. Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Apotex Inc. Main Business Overview
11.9.5 Apotex Inc. Latest Developments
11.10 Mylan Pharmaceuticals
11.10.1 Mylan Pharmaceuticals Company Information
11.10.2 Mylan Pharmaceuticals Drugs for Treating Mental Disorders Product Offered
11.10.3 Mylan Pharmaceuticals Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Mylan Pharmaceuticals Main Business Overview
11.10.5 Mylan Pharmaceuticals Latest Developments
11.11 Par Pharmaceutical
11.11.1 Par Pharmaceutical Company Information
11.11.2 Par Pharmaceutical Drugs for Treating Mental Disorders Product Offered
11.11.3 Par Pharmaceutical Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Par Pharmaceutical Main Business Overview
11.11.5 Par Pharmaceutical Latest Developments
11.12 Aurobindo Pharma
11.12.1 Aurobindo Pharma Company Information
11.12.2 Aurobindo Pharma Drugs for Treating Mental Disorders Product Offered
11.12.3 Aurobindo Pharma Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Aurobindo Pharma Main Business Overview
11.12.5 Aurobindo Pharma Latest Developments
11.13 Torrent Pharmaceuticals
11.13.1 Torrent Pharmaceuticals Company Information
11.13.2 Torrent Pharmaceuticals Drugs for Treating Mental Disorders Product Offered
11.13.3 Torrent Pharmaceuticals Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Torrent Pharmaceuticals Main Business Overview
11.13.5 Torrent Pharmaceuticals Latest Developments
11.14 Jubilant Lifesciences
11.14.1 Jubilant Lifesciences Company Information
11.14.2 Jubilant Lifesciences Drugs for Treating Mental Disorders Product Offered
11.14.3 Jubilant Lifesciences Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Jubilant Lifesciences Main Business Overview
11.14.5 Jubilant Lifesciences Latest Developments
11.15 Sun Pharmaceutical
11.15.1 Sun Pharmaceutical Company Information
11.15.2 Sun Pharmaceutical Drugs for Treating Mental Disorders Product Offered
11.15.3 Sun Pharmaceutical Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Sun Pharmaceutical Main Business Overview
11.15.5 Sun Pharmaceutical Latest Developments
11.16 Sandoz (Novartis)
11.16.1 Sandoz (Novartis) Company Information
11.16.2 Sandoz (Novartis) Drugs for Treating Mental Disorders Product Offered
11.16.3 Sandoz (Novartis) Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Sandoz (Novartis) Main Business Overview
11.16.5 Sandoz (Novartis) Latest Developments
11.17 Hansoh Pharmaceutical
11.17.1 Hansoh Pharmaceutical Company Information
11.17.2 Hansoh Pharmaceutical Drugs for Treating Mental Disorders Product Offered
11.17.3 Hansoh Pharmaceutical Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Hansoh Pharmaceutical Main Business Overview
11.17.5 Hansoh Pharmaceutical Latest Developments
11.18 WATSON Pharmaceuticals
11.18.1 WATSON Pharmaceuticals Company Information
11.18.2 WATSON Pharmaceuticals Drugs for Treating Mental Disorders Product Offered
11.18.3 WATSON Pharmaceuticals Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 WATSON Pharmaceuticals Main Business Overview
11.18.5 WATSON Pharmaceuticals Latest Developments
11.19 Zhejiang Langhua Pharmaceuticals
11.19.1 Zhejiang Langhua Pharmaceuticals Company Information
11.19.2 Zhejiang Langhua Pharmaceuticals Drugs for Treating Mental Disorders Product Offered
11.19.3 Zhejiang Langhua Pharmaceuticals Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 Zhejiang Langhua Pharmaceuticals Main Business Overview
11.19.5 Zhejiang Langhua Pharmaceuticals Latest Developments
11.20 Forest Laboratories
11.20.1 Forest Laboratories Company Information
11.20.2 Forest Laboratories Drugs for Treating Mental Disorders Product Offered
11.20.3 Forest Laboratories Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 Forest Laboratories Main Business Overview
11.20.5 Forest Laboratories Latest Developments
11.21 H.Lundbeck A/S
11.21.1 H.Lundbeck A/S Company Information
11.21.2 H.Lundbeck A/S Drugs for Treating Mental Disorders Product Offered
11.21.3 H.Lundbeck A/S Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.21.4 H.Lundbeck A/S Main Business Overview
11.21.5 H.Lundbeck A/S Latest Developments
11.22 Amneal Pharmaceuticals
11.22.1 Amneal Pharmaceuticals Company Information
11.22.2 Amneal Pharmaceuticals Drugs for Treating Mental Disorders Product Offered
11.22.3 Amneal Pharmaceuticals Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.22.4 Amneal Pharmaceuticals Main Business Overview
11.22.5 Amneal Pharmaceuticals Latest Developments
11.23 Hetero Drugs
11.23.1 Hetero Drugs Company Information
11.23.2 Hetero Drugs Drugs for Treating Mental Disorders Product Offered
11.23.3 Hetero Drugs Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.23.4 Hetero Drugs Main Business Overview
11.23.5 Hetero Drugs Latest Developments
11.24 Macleods Pharmaceuticals
11.24.1 Macleods Pharmaceuticals Company Information
11.24.2 Macleods Pharmaceuticals Drugs for Treating Mental Disorders Product Offered
11.24.3 Macleods Pharmaceuticals Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.24.4 Macleods Pharmaceuticals Main Business Overview
11.24.5 Macleods Pharmaceuticals Latest Developments
11.25 Silarx Pharmacueticals
11.25.1 Silarx Pharmacueticals Company Information
11.25.2 Silarx Pharmacueticals Drugs for Treating Mental Disorders Product Offered
11.25.3 Silarx Pharmacueticals Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.25.4 Silarx Pharmacueticals Main Business Overview
11.25.5 Silarx Pharmacueticals Latest Developments
11.26 Hikma Pharmaceuticals
11.26.1 Hikma Pharmaceuticals Company Information
11.26.2 Hikma Pharmaceuticals Drugs for Treating Mental Disorders Product Offered
11.26.3 Hikma Pharmaceuticals Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.26.4 Hikma Pharmaceuticals Main Business Overview
11.26.5 Hikma Pharmaceuticals Latest Developments
11.27 Lupin Limited
11.27.1 Lupin Limited Company Information
11.27.2 Lupin Limited Drugs for Treating Mental Disorders Product Offered
11.27.3 Lupin Limited Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.27.4 Lupin Limited Main Business Overview
11.27.5 Lupin Limited Latest Developments
11.28 Prinston Pharmaceutical
11.28.1 Prinston Pharmaceutical Company Information
11.28.2 Prinston Pharmaceutical Drugs for Treating Mental Disorders Product Offered
11.28.3 Prinston Pharmaceutical Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.28.4 Prinston Pharmaceutical Main Business Overview
11.28.5 Prinston Pharmaceutical Latest Developments
11.29 STI Pharma
11.29.1 STI Pharma Company Information
11.29.2 STI Pharma Drugs for Treating Mental Disorders Product Offered
11.29.3 STI Pharma Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.29.4 STI Pharma Main Business Overview
11.29.5 STI Pharma Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drugs for Treating Mental Disorders Market Size 2018-2029
2.1.2 Drugs for Treating Mental Disorders Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Drugs for Treating Mental Disorders Segment by Type
2.2.1 Tablets
2.2.2 Capsule
2.2.3 Injection
2.2.4 Solution
2.2.5 Other
2.3 Drugs for Treating Mental Disorders Market Size by Type
2.3.1 Drugs for Treating Mental Disorders Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Drugs for Treating Mental Disorders Market Size Market Share by Type (2018-2023)
2.4 Drugs for Treating Mental Disorders Segment by Application
2.4.1 Antipsychotics
2.4.2 Antidepressants
2.4.3 Antianxiety (Anxiolyitcs)
2.4.4 Anti-Seizure Medications
2.4.5 Stimulants
2.4.6 Cognitive Disorders And Dementia
2.4.7 Sleep Disorder Treatments
2.4.8 Substance Abuse Treatments
2.4.9 Hypnosis And Tranquilizers
2.4.10 Other
2.5 Drugs for Treating Mental Disorders Market Size by Application
2.5.1 Drugs for Treating Mental Disorders Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Drugs for Treating Mental Disorders Market Size Market Share by Application (2018-2023)
3 DRUGS FOR TREATING MENTAL DISORDERS MARKET SIZE BY PLAYER
3.1 Drugs for Treating Mental Disorders Market Size Market Share by Players
3.1.1 Global Drugs for Treating Mental Disorders Revenue by Players (2018-2023)
3.1.2 Global Drugs for Treating Mental Disorders Revenue Market Share by Players (2018-2023)
3.2 Global Drugs for Treating Mental Disorders Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 DRUGS FOR TREATING MENTAL DISORDERS BY REGIONS
4.1 Drugs for Treating Mental Disorders Market Size by Regions (2018-2023)
4.2 Americas Drugs for Treating Mental Disorders Market Size Growth (2018-2023)
4.3 APAC Drugs for Treating Mental Disorders Market Size Growth (2018-2023)
4.4 Europe Drugs for Treating Mental Disorders Market Size Growth (2018-2023)
4.5 Middle East & Africa Drugs for Treating Mental Disorders Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Drugs for Treating Mental Disorders Market Size by Country (2018-2023)
5.2 Americas Drugs for Treating Mental Disorders Market Size by Type (2018-2023)
5.3 Americas Drugs for Treating Mental Disorders Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drugs for Treating Mental Disorders Market Size by Region (2018-2023)
6.2 APAC Drugs for Treating Mental Disorders Market Size by Type (2018-2023)
6.3 APAC Drugs for Treating Mental Disorders Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Drugs for Treating Mental Disorders by Country (2018-2023)
7.2 Europe Drugs for Treating Mental Disorders Market Size by Type (2018-2023)
7.3 Europe Drugs for Treating Mental Disorders Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drugs for Treating Mental Disorders by Region (2018-2023)
8.2 Middle East & Africa Drugs for Treating Mental Disorders Market Size by Type (2018-2023)
8.3 Middle East & Africa Drugs for Treating Mental Disorders Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL DRUGS FOR TREATING MENTAL DISORDERS MARKET FORECAST
10.1 Global Drugs for Treating Mental Disorders Forecast by Regions (2024-2029)
10.1.1 Global Drugs for Treating Mental Disorders Forecast by Regions (2024-2029)
10.1.2 Americas Drugs for Treating Mental Disorders Forecast
10.1.3 APAC Drugs for Treating Mental Disorders Forecast
10.1.4 Europe Drugs for Treating Mental Disorders Forecast
10.1.5 Middle East & Africa Drugs for Treating Mental Disorders Forecast
10.2 Americas Drugs for Treating Mental Disorders Forecast by Country (2024-2029)
10.2.1 United States Drugs for Treating Mental Disorders Market Forecast
10.2.2 Canada Drugs for Treating Mental Disorders Market Forecast
10.2.3 Mexico Drugs for Treating Mental Disorders Market Forecast
10.2.4 Brazil Drugs for Treating Mental Disorders Market Forecast
10.3 APAC Drugs for Treating Mental Disorders Forecast by Region (2024-2029)
10.3.1 China Drugs for Treating Mental Disorders Market Forecast
10.3.2 Japan Drugs for Treating Mental Disorders Market Forecast
10.3.3 Korea Drugs for Treating Mental Disorders Market Forecast
10.3.4 Southeast Asia Drugs for Treating Mental Disorders Market Forecast
10.3.5 India Drugs for Treating Mental Disorders Market Forecast
10.3.6 Australia Drugs for Treating Mental Disorders Market Forecast
10.4 Europe Drugs for Treating Mental Disorders Forecast by Country (2024-2029)
10.4.1 Germany Drugs for Treating Mental Disorders Market Forecast
10.4.2 France Drugs for Treating Mental Disorders Market Forecast
10.4.3 UK Drugs for Treating Mental Disorders Market Forecast
10.4.4 Italy Drugs for Treating Mental Disorders Market Forecast
10.4.5 Russia Drugs for Treating Mental Disorders Market Forecast
10.5 Middle East & Africa Drugs for Treating Mental Disorders Forecast by Region (2024-2029)
10.5.1 Egypt Drugs for Treating Mental Disorders Market Forecast
10.5.2 South Africa Drugs for Treating Mental Disorders Market Forecast
10.5.3 Israel Drugs for Treating Mental Disorders Market Forecast
10.5.4 Turkey Drugs for Treating Mental Disorders Market Forecast
10.5.5 GCC Countries Drugs for Treating Mental Disorders Market Forecast
10.6 Global Drugs for Treating Mental Disorders Forecast by Type (2024-2029)
10.7 Global Drugs for Treating Mental Disorders Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Johnson and Johnson
11.1.1 Johnson and Johnson Company Information
11.1.2 Johnson and Johnson Drugs for Treating Mental Disorders Product Offered
11.1.3 Johnson and Johnson Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Johnson and Johnson Main Business Overview
11.1.5 Johnson and Johnson Latest Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Drugs for Treating Mental Disorders Product Offered
11.2.3 Pfizer Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Pfizer Main Business Overview
11.2.5 Pfizer Latest Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Company Information
11.3.2 Eli Lilly Drugs for Treating Mental Disorders Product Offered
11.3.3 Eli Lilly Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Eli Lilly Main Business Overview
11.3.5 Eli Lilly Latest Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Information
11.4.2 GlaxoSmithKline Drugs for Treating Mental Disorders Product Offered
11.4.3 GlaxoSmithKline Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 GlaxoSmithKline Main Business Overview
11.4.5 GlaxoSmithKline Latest Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Company Information
11.5.2 AstraZeneca Drugs for Treating Mental Disorders Product Offered
11.5.3 AstraZeneca Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 AstraZeneca Main Business Overview
11.5.5 AstraZeneca Latest Developments
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Information
11.6.2 Bristol-Myers Squibb Drugs for Treating Mental Disorders Product Offered
11.6.3 Bristol-Myers Squibb Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Bristol-Myers Squibb Main Business Overview
11.6.5 Bristol-Myers Squibb Latest Developments
11.7 Teva Pharmaceutical
11.7.1 Teva Pharmaceutical Company Information
11.7.2 Teva Pharmaceutical Drugs for Treating Mental Disorders Product Offered
11.7.3 Teva Pharmaceutical Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Teva Pharmaceutical Main Business Overview
11.7.5 Teva Pharmaceutical Latest Developments
11.8 Dr. Reddy's Laboratories
11.8.1 Dr. Reddy's Laboratories Company Information
11.8.2 Dr. Reddy's Laboratories Drugs for Treating Mental Disorders Product Offered
11.8.3 Dr. Reddy's Laboratories Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Dr. Reddy's Laboratories Main Business Overview
11.8.5 Dr. Reddy's Laboratories Latest Developments
11.9 Apotex Inc.
11.9.1 Apotex Inc. Company Information
11.9.2 Apotex Inc. Drugs for Treating Mental Disorders Product Offered
11.9.3 Apotex Inc. Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Apotex Inc. Main Business Overview
11.9.5 Apotex Inc. Latest Developments
11.10 Mylan Pharmaceuticals
11.10.1 Mylan Pharmaceuticals Company Information
11.10.2 Mylan Pharmaceuticals Drugs for Treating Mental Disorders Product Offered
11.10.3 Mylan Pharmaceuticals Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Mylan Pharmaceuticals Main Business Overview
11.10.5 Mylan Pharmaceuticals Latest Developments
11.11 Par Pharmaceutical
11.11.1 Par Pharmaceutical Company Information
11.11.2 Par Pharmaceutical Drugs for Treating Mental Disorders Product Offered
11.11.3 Par Pharmaceutical Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Par Pharmaceutical Main Business Overview
11.11.5 Par Pharmaceutical Latest Developments
11.12 Aurobindo Pharma
11.12.1 Aurobindo Pharma Company Information
11.12.2 Aurobindo Pharma Drugs for Treating Mental Disorders Product Offered
11.12.3 Aurobindo Pharma Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Aurobindo Pharma Main Business Overview
11.12.5 Aurobindo Pharma Latest Developments
11.13 Torrent Pharmaceuticals
11.13.1 Torrent Pharmaceuticals Company Information
11.13.2 Torrent Pharmaceuticals Drugs for Treating Mental Disorders Product Offered
11.13.3 Torrent Pharmaceuticals Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Torrent Pharmaceuticals Main Business Overview
11.13.5 Torrent Pharmaceuticals Latest Developments
11.14 Jubilant Lifesciences
11.14.1 Jubilant Lifesciences Company Information
11.14.2 Jubilant Lifesciences Drugs for Treating Mental Disorders Product Offered
11.14.3 Jubilant Lifesciences Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Jubilant Lifesciences Main Business Overview
11.14.5 Jubilant Lifesciences Latest Developments
11.15 Sun Pharmaceutical
11.15.1 Sun Pharmaceutical Company Information
11.15.2 Sun Pharmaceutical Drugs for Treating Mental Disorders Product Offered
11.15.3 Sun Pharmaceutical Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Sun Pharmaceutical Main Business Overview
11.15.5 Sun Pharmaceutical Latest Developments
11.16 Sandoz (Novartis)
11.16.1 Sandoz (Novartis) Company Information
11.16.2 Sandoz (Novartis) Drugs for Treating Mental Disorders Product Offered
11.16.3 Sandoz (Novartis) Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Sandoz (Novartis) Main Business Overview
11.16.5 Sandoz (Novartis) Latest Developments
11.17 Hansoh Pharmaceutical
11.17.1 Hansoh Pharmaceutical Company Information
11.17.2 Hansoh Pharmaceutical Drugs for Treating Mental Disorders Product Offered
11.17.3 Hansoh Pharmaceutical Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Hansoh Pharmaceutical Main Business Overview
11.17.5 Hansoh Pharmaceutical Latest Developments
11.18 WATSON Pharmaceuticals
11.18.1 WATSON Pharmaceuticals Company Information
11.18.2 WATSON Pharmaceuticals Drugs for Treating Mental Disorders Product Offered
11.18.3 WATSON Pharmaceuticals Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 WATSON Pharmaceuticals Main Business Overview
11.18.5 WATSON Pharmaceuticals Latest Developments
11.19 Zhejiang Langhua Pharmaceuticals
11.19.1 Zhejiang Langhua Pharmaceuticals Company Information
11.19.2 Zhejiang Langhua Pharmaceuticals Drugs for Treating Mental Disorders Product Offered
11.19.3 Zhejiang Langhua Pharmaceuticals Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 Zhejiang Langhua Pharmaceuticals Main Business Overview
11.19.5 Zhejiang Langhua Pharmaceuticals Latest Developments
11.20 Forest Laboratories
11.20.1 Forest Laboratories Company Information
11.20.2 Forest Laboratories Drugs for Treating Mental Disorders Product Offered
11.20.3 Forest Laboratories Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 Forest Laboratories Main Business Overview
11.20.5 Forest Laboratories Latest Developments
11.21 H.Lundbeck A/S
11.21.1 H.Lundbeck A/S Company Information
11.21.2 H.Lundbeck A/S Drugs for Treating Mental Disorders Product Offered
11.21.3 H.Lundbeck A/S Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.21.4 H.Lundbeck A/S Main Business Overview
11.21.5 H.Lundbeck A/S Latest Developments
11.22 Amneal Pharmaceuticals
11.22.1 Amneal Pharmaceuticals Company Information
11.22.2 Amneal Pharmaceuticals Drugs for Treating Mental Disorders Product Offered
11.22.3 Amneal Pharmaceuticals Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.22.4 Amneal Pharmaceuticals Main Business Overview
11.22.5 Amneal Pharmaceuticals Latest Developments
11.23 Hetero Drugs
11.23.1 Hetero Drugs Company Information
11.23.2 Hetero Drugs Drugs for Treating Mental Disorders Product Offered
11.23.3 Hetero Drugs Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.23.4 Hetero Drugs Main Business Overview
11.23.5 Hetero Drugs Latest Developments
11.24 Macleods Pharmaceuticals
11.24.1 Macleods Pharmaceuticals Company Information
11.24.2 Macleods Pharmaceuticals Drugs for Treating Mental Disorders Product Offered
11.24.3 Macleods Pharmaceuticals Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.24.4 Macleods Pharmaceuticals Main Business Overview
11.24.5 Macleods Pharmaceuticals Latest Developments
11.25 Silarx Pharmacueticals
11.25.1 Silarx Pharmacueticals Company Information
11.25.2 Silarx Pharmacueticals Drugs for Treating Mental Disorders Product Offered
11.25.3 Silarx Pharmacueticals Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.25.4 Silarx Pharmacueticals Main Business Overview
11.25.5 Silarx Pharmacueticals Latest Developments
11.26 Hikma Pharmaceuticals
11.26.1 Hikma Pharmaceuticals Company Information
11.26.2 Hikma Pharmaceuticals Drugs for Treating Mental Disorders Product Offered
11.26.3 Hikma Pharmaceuticals Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.26.4 Hikma Pharmaceuticals Main Business Overview
11.26.5 Hikma Pharmaceuticals Latest Developments
11.27 Lupin Limited
11.27.1 Lupin Limited Company Information
11.27.2 Lupin Limited Drugs for Treating Mental Disorders Product Offered
11.27.3 Lupin Limited Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.27.4 Lupin Limited Main Business Overview
11.27.5 Lupin Limited Latest Developments
11.28 Prinston Pharmaceutical
11.28.1 Prinston Pharmaceutical Company Information
11.28.2 Prinston Pharmaceutical Drugs for Treating Mental Disorders Product Offered
11.28.3 Prinston Pharmaceutical Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.28.4 Prinston Pharmaceutical Main Business Overview
11.28.5 Prinston Pharmaceutical Latest Developments
11.29 STI Pharma
11.29.1 STI Pharma Company Information
11.29.2 STI Pharma Drugs for Treating Mental Disorders Product Offered
11.29.3 STI Pharma Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2018-2023)
11.29.4 STI Pharma Main Business Overview
11.29.5 STI Pharma Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Drugs for Treating Mental Disorders Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Tablets
Table 3. Major Players of Capsule
Table 4. Major Players of Injection
Table 5. Major Players of Solution
Table 6. Major Players of Other
Table 7. Drugs for Treating Mental Disorders Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Drugs for Treating Mental Disorders Market Size by Type (2018-2023) & ($ Millions)
Table 9. Global Drugs for Treating Mental Disorders Market Size Market Share by Type (2018-2023)
Table 10. Drugs for Treating Mental Disorders Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 11. Global Drugs for Treating Mental Disorders Market Size by Application (2018-2023) & ($ Millions)
Table 12. Global Drugs for Treating Mental Disorders Market Size Market Share by Application (2018-2023)
Table 13. Global Drugs for Treating Mental Disorders Revenue by Players (2018-2023) & ($ Millions)
Table 14. Global Drugs for Treating Mental Disorders Revenue Market Share by Player (2018-2023)
Table 15. Drugs for Treating Mental Disorders Key Players Head office and Products Offered
Table 16. Drugs for Treating Mental Disorders Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Drugs for Treating Mental Disorders Market Size by Regions 2018-2023 & ($ Millions)
Table 20. Global Drugs for Treating Mental Disorders Market Size Market Share by Regions (2018-2023)
Table 21. Global Drugs for Treating Mental Disorders Revenue by Country/Region (2018-2023) & ($ millions)
Table 22. Global Drugs for Treating Mental Disorders Revenue Market Share by Country/Region (2018-2023)
Table 23. Americas Drugs for Treating Mental Disorders Market Size by Country (2018-2023) & ($ Millions)
Table 24. Americas Drugs for Treating Mental Disorders Market Size Market Share by Country (2018-2023)
Table 25. Americas Drugs for Treating Mental Disorders Market Size by Type (2018-2023) & ($ Millions)
Table 26. Americas Drugs for Treating Mental Disorders Market Size Market Share by Type (2018-2023)
Table 27. Americas Drugs for Treating Mental Disorders Market Size by Application (2018-2023) & ($ Millions)
Table 28. Americas Drugs for Treating Mental Disorders Market Size Market Share by Application (2018-2023)
Table 29. APAC Drugs for Treating Mental Disorders Market Size by Region (2018-2023) & ($ Millions)
Table 30. APAC Drugs for Treating Mental Disorders Market Size Market Share by Region (2018-2023)
Table 31. APAC Drugs for Treating Mental Disorders Market Size by Type (2018-2023) & ($ Millions)
Table 32. APAC Drugs for Treating Mental Disorders Market Size Market Share by Type (2018-2023)
Table 33. APAC Drugs for Treating Mental Disorders Market Size by Application (2018-2023) & ($ Millions)
Table 34. APAC Drugs for Treating Mental Disorders Market Size Market Share by Application (2018-2023)
Table 35. Europe Drugs for Treating Mental Disorders Market Size by Country (2018-2023) & ($ Millions)
Table 36. Europe Drugs for Treating Mental Disorders Market Size Market Share by Country (2018-2023)
Table 37. Europe Drugs for Treating Mental Disorders Market Size by Type (2018-2023) & ($ Millions)
Table 38. Europe Drugs for Treating Mental Disorders Market Size Market Share by Type (2018-2023)
Table 39. Europe Drugs for Treating Mental Disorders Market Size by Application (2018-2023) & ($ Millions)
Table 40. Europe Drugs for Treating Mental Disorders Market Size Market Share by Application (2018-2023)
Table 41. Middle East & Africa Drugs for Treating Mental Disorders Market Size by Region (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Drugs for Treating Mental Disorders Market Size Market Share by Region (2018-2023)
Table 43. Middle East & Africa Drugs for Treating Mental Disorders Market Size by Type (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Drugs for Treating Mental Disorders Market Size Market Share by Type (2018-2023)
Table 45. Middle East & Africa Drugs for Treating Mental Disorders Market Size by Application (2018-2023) & ($ Millions)
Table 46. Middle East & Africa Drugs for Treating Mental Disorders Market Size Market Share by Application (2018-2023)
Table 47. Key Market Drivers & Growth Opportunities of Drugs for Treating Mental Disorders
Table 48. Key Market Challenges & Risks of Drugs for Treating Mental Disorders
Table 49. Key Industry Trends of Drugs for Treating Mental Disorders
Table 50. Global Drugs for Treating Mental Disorders Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 51. Global Drugs for Treating Mental Disorders Market Size Market Share Forecast by Regions (2024-2029)
Table 52. Global Drugs for Treating Mental Disorders Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 53. Global Drugs for Treating Mental Disorders Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 54. Johnson and Johnson Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 55. Johnson and Johnson Drugs for Treating Mental Disorders Product Offered
Table 56. Johnson and Johnson Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 57. Johnson and Johnson Main Business
Table 58. Johnson and Johnson Latest Developments
Table 59. Pfizer Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 60. Pfizer Drugs for Treating Mental Disorders Product Offered
Table 61. Pfizer Main Business
Table 62. Pfizer Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 63. Pfizer Latest Developments
Table 64. Eli Lilly Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 65. Eli Lilly Drugs for Treating Mental Disorders Product Offered
Table 66. Eli Lilly Main Business
Table 67. Eli Lilly Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 68. Eli Lilly Latest Developments
Table 69. GlaxoSmithKline Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 70. GlaxoSmithKline Drugs for Treating Mental Disorders Product Offered
Table 71. GlaxoSmithKline Main Business
Table 72. GlaxoSmithKline Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 73. GlaxoSmithKline Latest Developments
Table 74. AstraZeneca Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 75. AstraZeneca Drugs for Treating Mental Disorders Product Offered
Table 76. AstraZeneca Main Business
Table 77. AstraZeneca Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 78. AstraZeneca Latest Developments
Table 79. Bristol-Myers Squibb Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 80. Bristol-Myers Squibb Drugs for Treating Mental Disorders Product Offered
Table 81. Bristol-Myers Squibb Main Business
Table 82. Bristol-Myers Squibb Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 83. Bristol-Myers Squibb Latest Developments
Table 84. Teva Pharmaceutical Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 85. Teva Pharmaceutical Drugs for Treating Mental Disorders Product Offered
Table 86. Teva Pharmaceutical Main Business
Table 87. Teva Pharmaceutical Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 88. Teva Pharmaceutical Latest Developments
Table 89. Dr. Reddy's Laboratories Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 90. Dr. Reddy's Laboratories Drugs for Treating Mental Disorders Product Offered
Table 91. Dr. Reddy's Laboratories Main Business
Table 92. Dr. Reddy's Laboratories Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 93. Dr. Reddy's Laboratories Latest Developments
Table 94. Apotex Inc. Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 95. Apotex Inc. Drugs for Treating Mental Disorders Product Offered
Table 96. Apotex Inc. Main Business
Table 97. Apotex Inc. Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 98. Apotex Inc. Latest Developments
Table 99. Mylan Pharmaceuticals Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 100. Mylan Pharmaceuticals Drugs for Treating Mental Disorders Product Offered
Table 101. Mylan Pharmaceuticals Main Business
Table 102. Mylan Pharmaceuticals Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 103. Mylan Pharmaceuticals Latest Developments
Table 104. Par Pharmaceutical Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 105. Par Pharmaceutical Drugs for Treating Mental Disorders Product Offered
Table 106. Par Pharmaceutical Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 107. Par Pharmaceutical Main Business
Table 108. Par Pharmaceutical Latest Developments
Table 109. Aurobindo Pharma Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 110. Aurobindo Pharma Drugs for Treating Mental Disorders Product Offered
Table 111. Aurobindo Pharma Main Business
Table 112. Aurobindo Pharma Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 113. Aurobindo Pharma Latest Developments
Table 114. Torrent Pharmaceuticals Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 115. Torrent Pharmaceuticals Drugs for Treating Mental Disorders Product Offered
Table 116. Torrent Pharmaceuticals Main Business
Table 117. Torrent Pharmaceuticals Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 118. Torrent Pharmaceuticals Latest Developments
Table 119. Jubilant Lifesciences Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 120. Jubilant Lifesciences Drugs for Treating Mental Disorders Product Offered
Table 121. Jubilant Lifesciences Main Business
Table 122. Jubilant Lifesciences Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 123. Jubilant Lifesciences Latest Developments
Table 124. Sun Pharmaceutical Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 125. Sun Pharmaceutical Drugs for Treating Mental Disorders Product Offered
Table 126. Sun Pharmaceutical Main Business
Table 127. Sun Pharmaceutical Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 128. Sun Pharmaceutical Latest Developments
Table 129. Sandoz (Novartis) Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 130. Sandoz (Novartis) Drugs for Treating Mental Disorders Product Offered
Table 131. Sandoz (Novartis) Main Business
Table 132. Sandoz (Novartis) Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 133. Sandoz (Novartis) Latest Developments
Table 134. Hansoh Pharmaceutical Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 135. Hansoh Pharmaceutical Drugs for Treating Mental Disorders Product Offered
Table 136. Hansoh Pharmaceutical Main Business
Table 137. Hansoh Pharmaceutical Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 138. Hansoh Pharmaceutical Latest Developments
Table 139. WATSON Pharmaceuticals Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 140. WATSON Pharmaceuticals Drugs for Treating Mental Disorders Product Offered
Table 141. WATSON Pharmaceuticals Main Business
Table 142. WATSON Pharmaceuticals Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 143. WATSON Pharmaceuticals Latest Developments
Table 144. Zhejiang Langhua Pharmaceuticals Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 145. Zhejiang Langhua Pharmaceuticals Drugs for Treating Mental Disorders Product Offered
Table 146. Zhejiang Langhua Pharmaceuticals Main Business
Table 147. Zhejiang Langhua Pharmaceuticals Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 148. Zhejiang Langhua Pharmaceuticals Latest Developments
Table 149. Forest Laboratories Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 150. Forest Laboratories Drugs for Treating Mental Disorders Product Offered
Table 151. Forest Laboratories Main Business
Table 152. Forest Laboratories Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 153. Forest Laboratories Latest Developments
Table 154. H.Lundbeck A/S Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 155. H.Lundbeck A/S Drugs for Treating Mental Disorders Product Offered
Table 156. H.Lundbeck A/S Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 157. H.Lundbeck A/S Main Business
Table 158. H.Lundbeck A/S Latest Developments
Table 159. Amneal Pharmaceuticals Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 160. Amneal Pharmaceuticals Drugs for Treating Mental Disorders Product Offered
Table 161. Amneal Pharmaceuticals Main Business
Table 162. Amneal Pharmaceuticals Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 163. Amneal Pharmaceuticals Latest Developments
Table 164. Hetero Drugs Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 165. Hetero Drugs Drugs for Treating Mental Disorders Product Offered
Table 166. Hetero Drugs Main Business
Table 167. Hetero Drugs Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 168. Hetero Drugs Latest Developments
Table 169. Macleods Pharmaceuticals Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 170. Macleods Pharmaceuticals Drugs for Treating Mental Disorders Product Offered
Table 171. Macleods Pharmaceuticals Main Business
Table 172. Macleods Pharmaceuticals Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 173. Macleods Pharmaceuticals Latest Developments
Table 174. Silarx Pharmacueticals Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 175. Silarx Pharmacueticals Drugs for Treating Mental Disorders Product Offered
Table 176. Silarx Pharmacueticals Main Business
Table 177. Silarx Pharmacueticals Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 178. Silarx Pharmacueticals Latest Developments
Table 179. Hikma Pharmaceuticals Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 180. Hikma Pharmaceuticals Drugs for Treating Mental Disorders Product Offered
Table 181. Hikma Pharmaceuticals Main Business
Table 182. Hikma Pharmaceuticals Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 183. Hikma Pharmaceuticals Latest Developments
Table 184. Lupin Limited Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 185. Lupin Limited Drugs for Treating Mental Disorders Product Offered
Table 186. Lupin Limited Main Business
Table 187. Lupin Limited Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 188. Lupin Limited Latest Developments
Table 189. Prinston Pharmaceutical Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 190. Prinston Pharmaceutical Drugs for Treating Mental Disorders Product Offered
Table 191. Prinston Pharmaceutical Main Business
Table 192. Prinston Pharmaceutical Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 193. Prinston Pharmaceutical Latest Developments
Table 194. STI Pharma Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 195. STI Pharma Drugs for Treating Mental Disorders Product Offered
Table 196. STI Pharma Main Business
Table 197. STI Pharma Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 198. STI Pharma Latest Developments
Table 1. Drugs for Treating Mental Disorders Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Tablets
Table 3. Major Players of Capsule
Table 4. Major Players of Injection
Table 5. Major Players of Solution
Table 6. Major Players of Other
Table 7. Drugs for Treating Mental Disorders Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Drugs for Treating Mental Disorders Market Size by Type (2018-2023) & ($ Millions)
Table 9. Global Drugs for Treating Mental Disorders Market Size Market Share by Type (2018-2023)
Table 10. Drugs for Treating Mental Disorders Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 11. Global Drugs for Treating Mental Disorders Market Size by Application (2018-2023) & ($ Millions)
Table 12. Global Drugs for Treating Mental Disorders Market Size Market Share by Application (2018-2023)
Table 13. Global Drugs for Treating Mental Disorders Revenue by Players (2018-2023) & ($ Millions)
Table 14. Global Drugs for Treating Mental Disorders Revenue Market Share by Player (2018-2023)
Table 15. Drugs for Treating Mental Disorders Key Players Head office and Products Offered
Table 16. Drugs for Treating Mental Disorders Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Drugs for Treating Mental Disorders Market Size by Regions 2018-2023 & ($ Millions)
Table 20. Global Drugs for Treating Mental Disorders Market Size Market Share by Regions (2018-2023)
Table 21. Global Drugs for Treating Mental Disorders Revenue by Country/Region (2018-2023) & ($ millions)
Table 22. Global Drugs for Treating Mental Disorders Revenue Market Share by Country/Region (2018-2023)
Table 23. Americas Drugs for Treating Mental Disorders Market Size by Country (2018-2023) & ($ Millions)
Table 24. Americas Drugs for Treating Mental Disorders Market Size Market Share by Country (2018-2023)
Table 25. Americas Drugs for Treating Mental Disorders Market Size by Type (2018-2023) & ($ Millions)
Table 26. Americas Drugs for Treating Mental Disorders Market Size Market Share by Type (2018-2023)
Table 27. Americas Drugs for Treating Mental Disorders Market Size by Application (2018-2023) & ($ Millions)
Table 28. Americas Drugs for Treating Mental Disorders Market Size Market Share by Application (2018-2023)
Table 29. APAC Drugs for Treating Mental Disorders Market Size by Region (2018-2023) & ($ Millions)
Table 30. APAC Drugs for Treating Mental Disorders Market Size Market Share by Region (2018-2023)
Table 31. APAC Drugs for Treating Mental Disorders Market Size by Type (2018-2023) & ($ Millions)
Table 32. APAC Drugs for Treating Mental Disorders Market Size Market Share by Type (2018-2023)
Table 33. APAC Drugs for Treating Mental Disorders Market Size by Application (2018-2023) & ($ Millions)
Table 34. APAC Drugs for Treating Mental Disorders Market Size Market Share by Application (2018-2023)
Table 35. Europe Drugs for Treating Mental Disorders Market Size by Country (2018-2023) & ($ Millions)
Table 36. Europe Drugs for Treating Mental Disorders Market Size Market Share by Country (2018-2023)
Table 37. Europe Drugs for Treating Mental Disorders Market Size by Type (2018-2023) & ($ Millions)
Table 38. Europe Drugs for Treating Mental Disorders Market Size Market Share by Type (2018-2023)
Table 39. Europe Drugs for Treating Mental Disorders Market Size by Application (2018-2023) & ($ Millions)
Table 40. Europe Drugs for Treating Mental Disorders Market Size Market Share by Application (2018-2023)
Table 41. Middle East & Africa Drugs for Treating Mental Disorders Market Size by Region (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Drugs for Treating Mental Disorders Market Size Market Share by Region (2018-2023)
Table 43. Middle East & Africa Drugs for Treating Mental Disorders Market Size by Type (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Drugs for Treating Mental Disorders Market Size Market Share by Type (2018-2023)
Table 45. Middle East & Africa Drugs for Treating Mental Disorders Market Size by Application (2018-2023) & ($ Millions)
Table 46. Middle East & Africa Drugs for Treating Mental Disorders Market Size Market Share by Application (2018-2023)
Table 47. Key Market Drivers & Growth Opportunities of Drugs for Treating Mental Disorders
Table 48. Key Market Challenges & Risks of Drugs for Treating Mental Disorders
Table 49. Key Industry Trends of Drugs for Treating Mental Disorders
Table 50. Global Drugs for Treating Mental Disorders Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 51. Global Drugs for Treating Mental Disorders Market Size Market Share Forecast by Regions (2024-2029)
Table 52. Global Drugs for Treating Mental Disorders Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 53. Global Drugs for Treating Mental Disorders Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 54. Johnson and Johnson Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 55. Johnson and Johnson Drugs for Treating Mental Disorders Product Offered
Table 56. Johnson and Johnson Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 57. Johnson and Johnson Main Business
Table 58. Johnson and Johnson Latest Developments
Table 59. Pfizer Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 60. Pfizer Drugs for Treating Mental Disorders Product Offered
Table 61. Pfizer Main Business
Table 62. Pfizer Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 63. Pfizer Latest Developments
Table 64. Eli Lilly Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 65. Eli Lilly Drugs for Treating Mental Disorders Product Offered
Table 66. Eli Lilly Main Business
Table 67. Eli Lilly Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 68. Eli Lilly Latest Developments
Table 69. GlaxoSmithKline Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 70. GlaxoSmithKline Drugs for Treating Mental Disorders Product Offered
Table 71. GlaxoSmithKline Main Business
Table 72. GlaxoSmithKline Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 73. GlaxoSmithKline Latest Developments
Table 74. AstraZeneca Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 75. AstraZeneca Drugs for Treating Mental Disorders Product Offered
Table 76. AstraZeneca Main Business
Table 77. AstraZeneca Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 78. AstraZeneca Latest Developments
Table 79. Bristol-Myers Squibb Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 80. Bristol-Myers Squibb Drugs for Treating Mental Disorders Product Offered
Table 81. Bristol-Myers Squibb Main Business
Table 82. Bristol-Myers Squibb Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 83. Bristol-Myers Squibb Latest Developments
Table 84. Teva Pharmaceutical Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 85. Teva Pharmaceutical Drugs for Treating Mental Disorders Product Offered
Table 86. Teva Pharmaceutical Main Business
Table 87. Teva Pharmaceutical Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 88. Teva Pharmaceutical Latest Developments
Table 89. Dr. Reddy's Laboratories Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 90. Dr. Reddy's Laboratories Drugs for Treating Mental Disorders Product Offered
Table 91. Dr. Reddy's Laboratories Main Business
Table 92. Dr. Reddy's Laboratories Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 93. Dr. Reddy's Laboratories Latest Developments
Table 94. Apotex Inc. Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 95. Apotex Inc. Drugs for Treating Mental Disorders Product Offered
Table 96. Apotex Inc. Main Business
Table 97. Apotex Inc. Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 98. Apotex Inc. Latest Developments
Table 99. Mylan Pharmaceuticals Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 100. Mylan Pharmaceuticals Drugs for Treating Mental Disorders Product Offered
Table 101. Mylan Pharmaceuticals Main Business
Table 102. Mylan Pharmaceuticals Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 103. Mylan Pharmaceuticals Latest Developments
Table 104. Par Pharmaceutical Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 105. Par Pharmaceutical Drugs for Treating Mental Disorders Product Offered
Table 106. Par Pharmaceutical Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 107. Par Pharmaceutical Main Business
Table 108. Par Pharmaceutical Latest Developments
Table 109. Aurobindo Pharma Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 110. Aurobindo Pharma Drugs for Treating Mental Disorders Product Offered
Table 111. Aurobindo Pharma Main Business
Table 112. Aurobindo Pharma Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 113. Aurobindo Pharma Latest Developments
Table 114. Torrent Pharmaceuticals Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 115. Torrent Pharmaceuticals Drugs for Treating Mental Disorders Product Offered
Table 116. Torrent Pharmaceuticals Main Business
Table 117. Torrent Pharmaceuticals Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 118. Torrent Pharmaceuticals Latest Developments
Table 119. Jubilant Lifesciences Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 120. Jubilant Lifesciences Drugs for Treating Mental Disorders Product Offered
Table 121. Jubilant Lifesciences Main Business
Table 122. Jubilant Lifesciences Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 123. Jubilant Lifesciences Latest Developments
Table 124. Sun Pharmaceutical Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 125. Sun Pharmaceutical Drugs for Treating Mental Disorders Product Offered
Table 126. Sun Pharmaceutical Main Business
Table 127. Sun Pharmaceutical Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 128. Sun Pharmaceutical Latest Developments
Table 129. Sandoz (Novartis) Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 130. Sandoz (Novartis) Drugs for Treating Mental Disorders Product Offered
Table 131. Sandoz (Novartis) Main Business
Table 132. Sandoz (Novartis) Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 133. Sandoz (Novartis) Latest Developments
Table 134. Hansoh Pharmaceutical Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 135. Hansoh Pharmaceutical Drugs for Treating Mental Disorders Product Offered
Table 136. Hansoh Pharmaceutical Main Business
Table 137. Hansoh Pharmaceutical Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 138. Hansoh Pharmaceutical Latest Developments
Table 139. WATSON Pharmaceuticals Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 140. WATSON Pharmaceuticals Drugs for Treating Mental Disorders Product Offered
Table 141. WATSON Pharmaceuticals Main Business
Table 142. WATSON Pharmaceuticals Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 143. WATSON Pharmaceuticals Latest Developments
Table 144. Zhejiang Langhua Pharmaceuticals Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 145. Zhejiang Langhua Pharmaceuticals Drugs for Treating Mental Disorders Product Offered
Table 146. Zhejiang Langhua Pharmaceuticals Main Business
Table 147. Zhejiang Langhua Pharmaceuticals Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 148. Zhejiang Langhua Pharmaceuticals Latest Developments
Table 149. Forest Laboratories Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 150. Forest Laboratories Drugs for Treating Mental Disorders Product Offered
Table 151. Forest Laboratories Main Business
Table 152. Forest Laboratories Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 153. Forest Laboratories Latest Developments
Table 154. H.Lundbeck A/S Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 155. H.Lundbeck A/S Drugs for Treating Mental Disorders Product Offered
Table 156. H.Lundbeck A/S Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 157. H.Lundbeck A/S Main Business
Table 158. H.Lundbeck A/S Latest Developments
Table 159. Amneal Pharmaceuticals Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 160. Amneal Pharmaceuticals Drugs for Treating Mental Disorders Product Offered
Table 161. Amneal Pharmaceuticals Main Business
Table 162. Amneal Pharmaceuticals Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 163. Amneal Pharmaceuticals Latest Developments
Table 164. Hetero Drugs Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 165. Hetero Drugs Drugs for Treating Mental Disorders Product Offered
Table 166. Hetero Drugs Main Business
Table 167. Hetero Drugs Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 168. Hetero Drugs Latest Developments
Table 169. Macleods Pharmaceuticals Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 170. Macleods Pharmaceuticals Drugs for Treating Mental Disorders Product Offered
Table 171. Macleods Pharmaceuticals Main Business
Table 172. Macleods Pharmaceuticals Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 173. Macleods Pharmaceuticals Latest Developments
Table 174. Silarx Pharmacueticals Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 175. Silarx Pharmacueticals Drugs for Treating Mental Disorders Product Offered
Table 176. Silarx Pharmacueticals Main Business
Table 177. Silarx Pharmacueticals Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 178. Silarx Pharmacueticals Latest Developments
Table 179. Hikma Pharmaceuticals Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 180. Hikma Pharmaceuticals Drugs for Treating Mental Disorders Product Offered
Table 181. Hikma Pharmaceuticals Main Business
Table 182. Hikma Pharmaceuticals Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 183. Hikma Pharmaceuticals Latest Developments
Table 184. Lupin Limited Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 185. Lupin Limited Drugs for Treating Mental Disorders Product Offered
Table 186. Lupin Limited Main Business
Table 187. Lupin Limited Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 188. Lupin Limited Latest Developments
Table 189. Prinston Pharmaceutical Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 190. Prinston Pharmaceutical Drugs for Treating Mental Disorders Product Offered
Table 191. Prinston Pharmaceutical Main Business
Table 192. Prinston Pharmaceutical Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 193. Prinston Pharmaceutical Latest Developments
Table 194. STI Pharma Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 195. STI Pharma Drugs for Treating Mental Disorders Product Offered
Table 196. STI Pharma Main Business
Table 197. STI Pharma Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 198. STI Pharma Latest Developments
LIST OF FIGURES
Figure 1. Drugs for Treating Mental Disorders Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Drugs for Treating Mental Disorders Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Drugs for Treating Mental Disorders Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Drugs for Treating Mental Disorders Sales Market Share by Country/Region (2022)
Figure 8. Drugs for Treating Mental Disorders Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Drugs for Treating Mental Disorders Market Size Market Share by Type in 2022
Figure 10. Drugs for Treating Mental Disorders in Antipsychotics
Figure 11. Global Drugs for Treating Mental Disorders Market: Antipsychotics (2018-2023) & ($ Millions)
Figure 12. Drugs for Treating Mental Disorders in Antidepressants
Figure 13. Global Drugs for Treating Mental Disorders Market: Antidepressants (2018-2023) & ($ Millions)
Figure 14. Drugs for Treating Mental Disorders in Antianxiety (Anxiolyitcs)
Figure 15. Global Drugs for Treating Mental Disorders Market: Antianxiety (Anxiolyitcs) (2018-2023) & ($ Millions)
Figure 16. Drugs for Treating Mental Disorders in Anti-Seizure Medications
Figure 17. Global Drugs for Treating Mental Disorders Market: Anti-Seizure Medications (2018-2023) & ($ Millions)
Figure 18. Drugs for Treating Mental Disorders in Stimulants
Figure 19. Global Drugs for Treating Mental Disorders Market: Stimulants (2018-2023) & ($ Millions)
Figure 20. Drugs for Treating Mental Disorders in Cognitive Disorders And Dementia
Figure 21. Global Drugs for Treating Mental Disorders Market: Cognitive Disorders And Dementia (2018-2023) & ($ Millions)
Figure 22. Drugs for Treating Mental Disorders in Sleep Disorder Treatments
Figure 23. Global Drugs for Treating Mental Disorders Market: Sleep Disorder Treatments (2018-2023) & ($ Millions)
Figure 24. Drugs for Treating Mental Disorders in Substance Abuse Treatments
Figure 25. Global Drugs for Treating Mental Disorders Market: Substance Abuse Treatments (2018-2023) & ($ Millions)
Figure 26. Drugs for Treating Mental Disorders in Hypnosis And Tranquilizers
Figure 27. Global Drugs for Treating Mental Disorders Market: Hypnosis And Tranquilizers (2018-2023) & ($ Millions)
Figure 28. Drugs for Treating Mental Disorders in Other
Figure 29. Global Drugs for Treating Mental Disorders Market: Other (2018-2023) & ($ Millions)
Figure 30. Global Drugs for Treating Mental Disorders Market Size Market Share by Application in 2022
Figure 31. Global Drugs for Treating Mental Disorders Revenue Market Share by Player in 2022
Figure 32. Global Drugs for Treating Mental Disorders Market Size Market Share by Regions (2018-2023)
Figure 33. Americas Drugs for Treating Mental Disorders Market Size 2018-2023 ($ Millions)
Figure 34. APAC Drugs for Treating Mental Disorders Market Size 2018-2023 ($ Millions)
Figure 35. Europe Drugs for Treating Mental Disorders Market Size 2018-2023 ($ Millions)
Figure 36. Middle East & Africa Drugs for Treating Mental Disorders Market Size 2018-2023 ($ Millions)
Figure 37. Americas Drugs for Treating Mental Disorders Value Market Share by Country in 2022
Figure 38. United States Drugs for Treating Mental Disorders Market Size Growth 2018-2023 ($ Millions)
Figure 39. Canada Drugs for Treating Mental Disorders Market Size Growth 2018-2023 ($ Millions)
Figure 40. Mexico Drugs for Treating Mental Disorders Market Size Growth 2018-2023 ($ Millions)
Figure 41. Brazil Drugs for Treating Mental Disorders Market Size Growth 2018-2023 ($ Millions)
Figure 42. APAC Drugs for Treating Mental Disorders Market Size Market Share by Region in 2022
Figure 43. APAC Drugs for Treating Mental Disorders Market Size Market Share by Type in 2022
Figure 44. APAC Drugs for Treating Mental Disorders Market Size Market Share by Application in 2022
Figure 45. China Drugs for Treating Mental Disorders Market Size Growth 2018-2023 ($ Millions)
Figure 46. Japan Drugs for Treating Mental Disorders Market Size Growth 2018-2023 ($ Millions)
Figure 47. Korea Drugs for Treating Mental Disorders Market Size Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Drugs for Treating Mental Disorders Market Size Growth 2018-2023 ($ Millions)
Figure 49. India Drugs for Treating Mental Disorders Market Size Growth 2018-2023 ($ Millions)
Figure 50. Australia Drugs for Treating Mental Disorders Market Size Growth 2018-2023 ($ Millions)
Figure 51. Europe Drugs for Treating Mental Disorders Market Size Market Share by Country in 2022
Figure 52. Europe Drugs for Treating Mental Disorders Market Size Market Share by Type (2018-2023)
Figure 53. Europe Drugs for Treating Mental Disorders Market Size Market Share by Application (2018-2023)
Figure 54. Germany Drugs for Treating Mental Disorders Market Size Growth 2018-2023 ($ Millions)
Figure 55. France Drugs for Treating Mental Disorders Market Size Growth 2018-2023 ($ Millions)
Figure 56. UK Drugs for Treating Mental Disorders Market Size Growth 2018-2023 ($ Millions)
Figure 57. Italy Drugs for Treating Mental Disorders Market Size Growth 2018-2023 ($ Millions)
Figure 58. Russia Drugs for Treating Mental Disorders Market Size Growth 2018-2023 ($ Millions)
Figure 59. Middle East & Africa Drugs for Treating Mental Disorders Market Size Market Share by Region (2018-2023)
Figure 60. Middle East & Africa Drugs for Treating Mental Disorders Market Size Market Share by Type (2018-2023)
Figure 61. Middle East & Africa Drugs for Treating Mental Disorders Market Size Market Share by Application (2018-2023)
Figure 62. Egypt Drugs for Treating Mental Disorders Market Size Growth 2018-2023 ($ Millions)
Figure 63. South Africa Drugs for Treating Mental Disorders Market Size Growth 2018-2023 ($ Millions)
Figure 64. Israel Drugs for Treating Mental Disorders Market Size Growth 2018-2023 ($ Millions)
Figure 65. Turkey Drugs for Treating Mental Disorders Market Size Growth 2018-2023 ($ Millions)
Figure 66. GCC Country Drugs for Treating Mental Disorders Market Size Growth 2018-2023 ($ Millions)
Figure 67. Americas Drugs for Treating Mental Disorders Market Size 2024-2029 ($ Millions)
Figure 68. APAC Drugs for Treating Mental Disorders Market Size 2024-2029 ($ Millions)
Figure 69. Europe Drugs for Treating Mental Disorders Market Size 2024-2029 ($ Millions)
Figure 70. Middle East & Africa Drugs for Treating Mental Disorders Market Size 2024-2029 ($ Millions)
Figure 71. United States Drugs for Treating Mental Disorders Market Size 2024-2029 ($ Millions)
Figure 72. Canada Drugs for Treating Mental Disorders Market Size 2024-2029 ($ Millions)
Figure 73. Mexico Drugs for Treating Mental Disorders Market Size 2024-2029 ($ Millions)
Figure 74. Brazil Drugs for Treating Mental Disorders Market Size 2024-2029 ($ Millions)
Figure 75. China Drugs for Treating Mental Disorders Market Size 2024-2029 ($ Millions)
Figure 76. Japan Drugs for Treating Mental Disorders Market Size 2024-2029 ($ Millions)
Figure 77. Korea Drugs for Treating Mental Disorders Market Size 2024-2029 ($ Millions)
Figure 78. Southeast Asia Drugs for Treating Mental Disorders Market Size 2024-2029 ($ Millions)
Figure 79. India Drugs for Treating Mental Disorders Market Size 2024-2029 ($ Millions)
Figure 80. Australia Drugs for Treating Mental Disorders Market Size 2024-2029 ($ Millions)
Figure 81. Germany Drugs for Treating Mental Disorders Market Size 2024-2029 ($ Millions)
Figure 82. France Drugs for Treating Mental Disorders Market Size 2024-2029 ($ Millions)
Figure 83. UK Drugs for Treating Mental Disorders Market Size 2024-2029 ($ Millions)
Figure 84. Italy Drugs for Treating Mental Disorders Market Size 2024-2029 ($ Millions)
Figure 85. Russia Drugs for Treating Mental Disorders Market Size 2024-2029 ($ Millions)
Figure 86. Spain Drugs for Treating Mental Disorders Market Size 2024-2029 ($ Millions)
Figure 87. Egypt Drugs for Treating Mental Disorders Market Size 2024-2029 ($ Millions)
Figure 88. South Africa Drugs for Treating Mental Disorders Market Size 2024-2029 ($ Millions)
Figure 89. Israel Drugs for Treating Mental Disorders Market Size 2024-2029 ($ Millions)
Figure 90. Turkey Drugs for Treating Mental Disorders Market Size 2024-2029 ($ Millions)
Figure 91. GCC Countries Drugs for Treating Mental Disorders Market Size 2024-2029 ($ Millions)
Figure 92. Global Drugs for Treating Mental Disorders Market Size Market Share Forecast by Type (2024-2029)
Figure 93. Global Drugs for Treating Mental Disorders Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Drugs for Treating Mental Disorders Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Drugs for Treating Mental Disorders Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Drugs for Treating Mental Disorders Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Drugs for Treating Mental Disorders Sales Market Share by Country/Region (2022)
Figure 8. Drugs for Treating Mental Disorders Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Drugs for Treating Mental Disorders Market Size Market Share by Type in 2022
Figure 10. Drugs for Treating Mental Disorders in Antipsychotics
Figure 11. Global Drugs for Treating Mental Disorders Market: Antipsychotics (2018-2023) & ($ Millions)
Figure 12. Drugs for Treating Mental Disorders in Antidepressants
Figure 13. Global Drugs for Treating Mental Disorders Market: Antidepressants (2018-2023) & ($ Millions)
Figure 14. Drugs for Treating Mental Disorders in Antianxiety (Anxiolyitcs)
Figure 15. Global Drugs for Treating Mental Disorders Market: Antianxiety (Anxiolyitcs) (2018-2023) & ($ Millions)
Figure 16. Drugs for Treating Mental Disorders in Anti-Seizure Medications
Figure 17. Global Drugs for Treating Mental Disorders Market: Anti-Seizure Medications (2018-2023) & ($ Millions)
Figure 18. Drugs for Treating Mental Disorders in Stimulants
Figure 19. Global Drugs for Treating Mental Disorders Market: Stimulants (2018-2023) & ($ Millions)
Figure 20. Drugs for Treating Mental Disorders in Cognitive Disorders And Dementia
Figure 21. Global Drugs for Treating Mental Disorders Market: Cognitive Disorders And Dementia (2018-2023) & ($ Millions)
Figure 22. Drugs for Treating Mental Disorders in Sleep Disorder Treatments
Figure 23. Global Drugs for Treating Mental Disorders Market: Sleep Disorder Treatments (2018-2023) & ($ Millions)
Figure 24. Drugs for Treating Mental Disorders in Substance Abuse Treatments
Figure 25. Global Drugs for Treating Mental Disorders Market: Substance Abuse Treatments (2018-2023) & ($ Millions)
Figure 26. Drugs for Treating Mental Disorders in Hypnosis And Tranquilizers
Figure 27. Global Drugs for Treating Mental Disorders Market: Hypnosis And Tranquilizers (2018-2023) & ($ Millions)
Figure 28. Drugs for Treating Mental Disorders in Other
Figure 29. Global Drugs for Treating Mental Disorders Market: Other (2018-2023) & ($ Millions)
Figure 30. Global Drugs for Treating Mental Disorders Market Size Market Share by Application in 2022
Figure 31. Global Drugs for Treating Mental Disorders Revenue Market Share by Player in 2022
Figure 32. Global Drugs for Treating Mental Disorders Market Size Market Share by Regions (2018-2023)
Figure 33. Americas Drugs for Treating Mental Disorders Market Size 2018-2023 ($ Millions)
Figure 34. APAC Drugs for Treating Mental Disorders Market Size 2018-2023 ($ Millions)
Figure 35. Europe Drugs for Treating Mental Disorders Market Size 2018-2023 ($ Millions)
Figure 36. Middle East & Africa Drugs for Treating Mental Disorders Market Size 2018-2023 ($ Millions)
Figure 37. Americas Drugs for Treating Mental Disorders Value Market Share by Country in 2022
Figure 38. United States Drugs for Treating Mental Disorders Market Size Growth 2018-2023 ($ Millions)
Figure 39. Canada Drugs for Treating Mental Disorders Market Size Growth 2018-2023 ($ Millions)
Figure 40. Mexico Drugs for Treating Mental Disorders Market Size Growth 2018-2023 ($ Millions)
Figure 41. Brazil Drugs for Treating Mental Disorders Market Size Growth 2018-2023 ($ Millions)
Figure 42. APAC Drugs for Treating Mental Disorders Market Size Market Share by Region in 2022
Figure 43. APAC Drugs for Treating Mental Disorders Market Size Market Share by Type in 2022
Figure 44. APAC Drugs for Treating Mental Disorders Market Size Market Share by Application in 2022
Figure 45. China Drugs for Treating Mental Disorders Market Size Growth 2018-2023 ($ Millions)
Figure 46. Japan Drugs for Treating Mental Disorders Market Size Growth 2018-2023 ($ Millions)
Figure 47. Korea Drugs for Treating Mental Disorders Market Size Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Drugs for Treating Mental Disorders Market Size Growth 2018-2023 ($ Millions)
Figure 49. India Drugs for Treating Mental Disorders Market Size Growth 2018-2023 ($ Millions)
Figure 50. Australia Drugs for Treating Mental Disorders Market Size Growth 2018-2023 ($ Millions)
Figure 51. Europe Drugs for Treating Mental Disorders Market Size Market Share by Country in 2022
Figure 52. Europe Drugs for Treating Mental Disorders Market Size Market Share by Type (2018-2023)
Figure 53. Europe Drugs for Treating Mental Disorders Market Size Market Share by Application (2018-2023)
Figure 54. Germany Drugs for Treating Mental Disorders Market Size Growth 2018-2023 ($ Millions)
Figure 55. France Drugs for Treating Mental Disorders Market Size Growth 2018-2023 ($ Millions)
Figure 56. UK Drugs for Treating Mental Disorders Market Size Growth 2018-2023 ($ Millions)
Figure 57. Italy Drugs for Treating Mental Disorders Market Size Growth 2018-2023 ($ Millions)
Figure 58. Russia Drugs for Treating Mental Disorders Market Size Growth 2018-2023 ($ Millions)
Figure 59. Middle East & Africa Drugs for Treating Mental Disorders Market Size Market Share by Region (2018-2023)
Figure 60. Middle East & Africa Drugs for Treating Mental Disorders Market Size Market Share by Type (2018-2023)
Figure 61. Middle East & Africa Drugs for Treating Mental Disorders Market Size Market Share by Application (2018-2023)
Figure 62. Egypt Drugs for Treating Mental Disorders Market Size Growth 2018-2023 ($ Millions)
Figure 63. South Africa Drugs for Treating Mental Disorders Market Size Growth 2018-2023 ($ Millions)
Figure 64. Israel Drugs for Treating Mental Disorders Market Size Growth 2018-2023 ($ Millions)
Figure 65. Turkey Drugs for Treating Mental Disorders Market Size Growth 2018-2023 ($ Millions)
Figure 66. GCC Country Drugs for Treating Mental Disorders Market Size Growth 2018-2023 ($ Millions)
Figure 67. Americas Drugs for Treating Mental Disorders Market Size 2024-2029 ($ Millions)
Figure 68. APAC Drugs for Treating Mental Disorders Market Size 2024-2029 ($ Millions)
Figure 69. Europe Drugs for Treating Mental Disorders Market Size 2024-2029 ($ Millions)
Figure 70. Middle East & Africa Drugs for Treating Mental Disorders Market Size 2024-2029 ($ Millions)
Figure 71. United States Drugs for Treating Mental Disorders Market Size 2024-2029 ($ Millions)
Figure 72. Canada Drugs for Treating Mental Disorders Market Size 2024-2029 ($ Millions)
Figure 73. Mexico Drugs for Treating Mental Disorders Market Size 2024-2029 ($ Millions)
Figure 74. Brazil Drugs for Treating Mental Disorders Market Size 2024-2029 ($ Millions)
Figure 75. China Drugs for Treating Mental Disorders Market Size 2024-2029 ($ Millions)
Figure 76. Japan Drugs for Treating Mental Disorders Market Size 2024-2029 ($ Millions)
Figure 77. Korea Drugs for Treating Mental Disorders Market Size 2024-2029 ($ Millions)
Figure 78. Southeast Asia Drugs for Treating Mental Disorders Market Size 2024-2029 ($ Millions)
Figure 79. India Drugs for Treating Mental Disorders Market Size 2024-2029 ($ Millions)
Figure 80. Australia Drugs for Treating Mental Disorders Market Size 2024-2029 ($ Millions)
Figure 81. Germany Drugs for Treating Mental Disorders Market Size 2024-2029 ($ Millions)
Figure 82. France Drugs for Treating Mental Disorders Market Size 2024-2029 ($ Millions)
Figure 83. UK Drugs for Treating Mental Disorders Market Size 2024-2029 ($ Millions)
Figure 84. Italy Drugs for Treating Mental Disorders Market Size 2024-2029 ($ Millions)
Figure 85. Russia Drugs for Treating Mental Disorders Market Size 2024-2029 ($ Millions)
Figure 86. Spain Drugs for Treating Mental Disorders Market Size 2024-2029 ($ Millions)
Figure 87. Egypt Drugs for Treating Mental Disorders Market Size 2024-2029 ($ Millions)
Figure 88. South Africa Drugs for Treating Mental Disorders Market Size 2024-2029 ($ Millions)
Figure 89. Israel Drugs for Treating Mental Disorders Market Size 2024-2029 ($ Millions)
Figure 90. Turkey Drugs for Treating Mental Disorders Market Size 2024-2029 ($ Millions)
Figure 91. GCC Countries Drugs for Treating Mental Disorders Market Size 2024-2029 ($ Millions)
Figure 92. Global Drugs for Treating Mental Disorders Market Size Market Share Forecast by Type (2024-2029)
Figure 93. Global Drugs for Treating Mental Disorders Market Size Market Share Forecast by Application (2024-2029)
